Vela purchased Great Basin for $1.4 million in June, and will reopen its Utah-based lab, rehire employees, and commercialize the firm's infectious disease platform.
The South Korean company said the kit not only detects Zika, but is also set up to find multiple mosquito-borne diseases such as Dengue and Chikunguya.
Under the agreement, Lucigen will use the CleanAmp dNTPs in its Taq98 Hot Start 2X MasterMix.
TriLink hopes that these modifications will provide the same benefit as hot-start approaches for PCR; namely, a substantial improvement in specificity and performance compared to conventional LCR.
Meridian Bioscience's acquisition of Bioline both provides Meridian a foothold in the PCR market and is expected to help drive future diagnostic development at the company.
Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.
The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.
Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.
In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.